ACHN Overview
Upcoming Projects (ACHN)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (ACHN)
-
Don’t see a project related to the company you care about? Create your own!
Upcoming & Overdue Catalysts (ACHN)
-
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (ACHN)
-
Data released from Achillion's (ACHN) Phase 1 multiple ascending dose study of ACH-5228 factor D inhibitor
Ticker: ACHN
Occurred on: Jul 22, 2019 -
Achillion (ACHN) Expects Interim Phase 1 MAD Results in H1 2017 Evaluating ACH-4471 in Healthy Volunteers
Ticker: ACHN
Occurred on: Aug 08, 2017 -
Achillion (ACHN) Presents on ACH-4471 at the 58th Annual Meeting of the American Society of Hematology (ASH)
Ticker: ACHN
Occurred on: Dec 05, 2016 -
Phase 2a topline SVR data of Odalasvir, simeprevir and ALS-335 for Hepatitis C viral infection (HCV) due 1Q 2016
Ticker: ACHN
Occurred on: Sep 09, 2016 -
Interim clinical data from ACH-4471 study expected during the second quarter of 2016
Ticker: ACHN
Occurred on: Jun 10, 2016 -
Achillion Initiates Phase 1 Study of ACH-4471, First Orally-Administered Small Molecule Complement Factor D Inhibitor
Ticker: ACHN
Occurred on: Feb 11, 2016
Strategic Initiatives (ACHN)
-
U.S. Federal Trade Commission has granted early termination of the waiting period for Achillion(ACHN) acquisition by Alexion Pharmaceuticals (ALXN) for $930M
Tickers: ACHN, ALXN
Announcement Date: Jan 27, 2020
